Alcoholic Steatohepatitis

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Fatty Liver, Alcoholic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
EASL clinical practical guidelines: management of alcoholic liver disease.
Alcoholic liver disease (ALD) is the most prevalent cause of advanced liver disease in Europe. However, there has been limited… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
BACKGROUND Fatty acid translocase CD36 (FAT/CD36) mediates uptake and intracellular transport of long-chain fatty acids in… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2010
2010
Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
BACKGROUND Non-alcoholic steatohepatitis (NASH) is a serious form of non-alcoholic fatty liver disease (NAFLD), associated with… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats.
BACKGROUND/AIMS Not all alcoholics develop liver disease (ALD). Thus, excessive ethanol consumption is necessary, but not… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis.
Because only 30% of alcoholics develop alcoholic liver disease (ALD), a factor other than heavy alcohol consumption must be… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis.
BACKGROUND AND AIM Advanced glycation end products (AGE), senescent macroprotein derivatives formed at an accelerated rate in… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Adiponectin and its receptors in non-alcoholic steatohepatitis.
BACKGROUND Adiponectin, an adipocyte derived polypeptide, has been shown to alleviate steatosis and inflammation in mice with non… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients
OBJECTIVES:The increasing incidence of nonalcoholic (NASH) and alcoholic steatohepatitis (ASH), associated with lack of effective… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis.
BACKGROUND AND AIM Non-alcoholic steatohepatitis (NASH), the association of steatosis with an inflammatory response, is a novel… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
Nonalcoholic steatohepatitis (NASH) has multiple etiologic associations, but the pathogenesis is poorly understood. Cytochrome… (More)
Is this relevant?